Method for preparing erlotinib

An erlotinib and compound technology, which is applied in the field of synthesis for the preparation of erlotinib, can solve problems such as unfavorable purification and quality research, unstable placement, unfavorable storage, etc., achieves simple operation, avoids long reaction steps, and achieves quality control. handy effect

Inactive Publication Date: 2017-05-31
CHONGQING SHENGHUAXI PHARMA CO LTD
View PDF6 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

This technology allows for efficient production of Erotini® without these drawbacks such as lengthy reactions, poor stability during intermediate products, difficulty controlling impurities, complex procedures that require multiple manipulation, etcetera. It also provides better results with fewer process stages, simpler handling, easier-to-control qualifications, less expensive materials compared to current processes.

Problems solved by technology

This patented technology describes different ways to make medicine called molecule culleris radiosynthesis in order to treat cancers like small lung carcinoma. However, current methods require expensive chemical agents such as dichloro benzamidazolone and acroleum sulfonide. Therefore, this new method needs to be developed without requiring harmful solvents while still producing effective results on certain types of tumors.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for preparing erlotinib
  • Method for preparing erlotinib
  • Method for preparing erlotinib

Examples

Experimental program
Comparison scheme
Effect test

reference example 1

[0020] Reference example 1 Preparation of the compound of formula one (refer to the patent "WO2007138613" EXAMPLES (d))

[0021] Add 10g of 4,5-bis(2-methoxyethoxy)-2-nitro-benzonitrile to 75mL of acetic acid and 75mL of water, stir for 10min, add 7g of iron powder in batches, after the addition is complete, stir at 30°C React for 30 minutes. After the reaction was completed, adjust the pH to 7 with alkaline water, extract with ethyl acetate, dry the ethyl acetate layer over anhydrous sodium sulfate, concentrate, and recrystallize from methanol to obtain 6 g of the compound of formula 1.

Embodiment 1

[0022] Embodiment 1 Preparation of Erlotinib

[0023] Add formula 1 (20.0g, 0.075mol), formula 2 (8.8g, 0.075mol), formula 3 (10.7g, 0.09mol), and 200mL of acetic acid in a 250mL three-neck flask. After the addition, the temperature was raised to 100°C for 3 hours. After the reaction was completed, the reaction solution was concentrated to about 100mL, poured into 200mL of ice water, then adjusted to pH 7~8 with NaOH aqueous solution, and the solid was precipitated, filtered with suction, and the filter cake was recrystallized from 100mL of ethyl acetate to obtain 23.6g of erlotinib, mole Yield 80%, HPLC content 99.2%.

Embodiment 2

[0024] Embodiment 2 Preparation of Erlotinib

[0025] Add formula 1 (20.0g, 0.075mol), formula 2 (9.7g, 0.0825mol), formula 3 (17.9g, 0.15mol), and 200mL of acetic acid into a 250mL three-neck flask in sequence. After the addition, the temperature was raised to 110°C for 2 hours. After the reaction was completed, the reaction solution was concentrated to about 100mL, poured into 200mL of ice water, then adjusted to pH 7~8 with NaOH aqueous solution, and the solid was precipitated, filtered by suction, and the filter cake was recrystallized from 100mL of ethyl acetate to obtain 24.5g of erlotinib, mol The yield is 83% (based on formula 1), and the HPLC content is 99.5%.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a method for preparing erlotinib. The method comprises the following steps: mixing compounds of formula I, formula II and formula III as shown in the specification, and performing a reaction on the three compounds, thereby obtaining erlotinib. The method is short in reaction step, simple and convenient to operate, convenient in quality control, relatively high in yield and relatively low in cost.

Description

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Owner CHONGQING SHENGHUAXI PHARMA CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products